Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
【発明の名称】カルシウム受容体活性化分子
Document Type and Number:
Japanese Patent JP2728564
Kind Code:
B2
Abstract:
Method and composition useful for treating a patient having a disease characterized by an abnormal level of one or more components, the activity of which is regulated or affected by activity of one or more Ca2+ receptors. Novel compounds useful in these methods and compositions are also provided. The method includes administering to the patient a therapeutically effective amount of a molecule active at one or more Ca2+ receptors as an agonist or antagonist. Preferably, the molecule is able to act as either a selective agonist or antagonist at a Ca2+ receptor of one or more but not all cells chosen from the group consisting of parathyroid cells, bone osteoclasts, juxtaglomerular kidney cells, proximal tubule kidney cells, keratinocytes, parafollicular thyroid cells and placental throphoblasts and a pharmaceutically acceptable carrier.

Inventors:
NEMESU EDOWAADO EFU
UAN UEIJINEN BURATSUDOFUOODO SHII
BARANDORIN MANYUERU EFU
Application Number:
JP50465092A
Publication Date:
March 18, 1998
Filing Date:
August 21, 1992
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ENU PII ESU PHARM INC
International Classes:
G01N33/15; A61K31/13; A61K31/135; A61K31/14; A61K31/16; A61K31/165; A61K31/235; A61K31/275; A61K31/395; A61K31/40; A61K31/403; A61K31/404; A61K31/44; A61K31/55; A61K31/554; A61K31/715; A61K31/785; A61K33/06; A61K38/00; A61K38/16; A61K45/00; A61P3/00; A61P3/14; A61P5/18; A61P5/22; A61P9/00; A61P9/12; A61P19/08; A61P19/10; A61P43/00; C07C211/02; C07C211/03; C07C211/15; C07C211/16; C07C211/17; C07C211/19; C07C211/26; C07C211/27; C07C211/29; C07C211/30; C07C211/42; C07C215/46; C07C215/48; C07C215/50; C07C215/52; C07C217/54; C07C217/56; C07C217/58; C07C217/60; C07C219/14; C07C225/16; C07C229/38; C07C233/05; C07C235/34; C07C235/44; C07C237/22; C07C237/30; C07C255/24; C07C255/45; C07C255/58; C07C279/14; C07C323/18; C07C323/32; C07D209/14; C07D209/16; C07D209/18; C07D209/30; C07D209/40; C07D211/90; C07D213/28; C07D213/36; C07D213/38; C07D215/12; C07D215/14; C07D233/54; C07D257/02; C07D281/10; C07D295/00; C07D413/04; C07H21/00; C07K5/00; C07K7/00; C07K14/435; C07K14/705; C08G69/10; C12N5/10; C12N15/09; C12N15/12; C12Q1/02; G01N33/50; G01N33/566; G01N33/567; G01N33/574; G01N33/68; G01N33/84; C12R1/91; A61K; G01N; (IPC1-7): C07C211/30; A61K31/13; A61K31/135; C07C211/17; C07C211/27; C07C211/29; C07C215/48; C07C217/56; C07C225/16
Attorney, Agent or Firm:
Kazuo Shamoto (5 outside)